Advertisement

FDA OKs 1st Generic Version of Popular Advair Asthma Inhaler

FDA OKs 1st Generic Version of Popular Advair Asthma Inhaler

LINDA A. JOHNSON, AP Medical Writer
Created: January 31, 2019 02:03 PM

The first generic version of the popular Advair asthma inhaler has been approved by U.S. regulators.

Advertisement – Content Continues Below

The Food and Drug Administration on Wednesday approved Mylan's version in three strengths for ages 4 and up.

The inhalers are used twice daily to keep airways open and prevent flare-ups of wheezing, shortness of breath and other symptoms of asthma or chronic obstructive pulmonary disease. About 42 million Americans have those conditions.

The device contains two medicines, inhaled in a precise mixture. That complexity has stymied a couple of other companies developing generic versions of GlaxoSmithKline's Advair Diskus inhaler, which costs about $400 a month.

Generics generally are cheaper. Mylan didn't immediately respond to queries about when its inhaler, called Wixela Inhub, will be available or what the price will be.

Credits

LINDA A. JOHNSON, AP Medical Writer

Copyright 2019 The Associated Press. All rights reserved.

Advertisement
Advertisement
Relay Media Amp

UMD Kicks Off Weekend Conference on #MeToo Movement and Sexual Assault Prevention

Warm and Dry Weather Presents Fire Concerns

UMD Grad, Entrepreneur Develops App Aimed to Tackle 'Loneliness Epidemic'

St. Croix Tribal Leaders Accused of Embezzling $1.5M from Casino

Brighton Beach, Enger Park Reopen; Parts of Skyline Still Closed

Tips Sought on Northern Wis. Dog Poisonings

Advertisement